SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Monte Rosa Therapeutics management to participate in investor conferences

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) said management will participate in upcoming investor conferences, with a webcast of the fireside chat planned.

GLUE

BOSTON, Sept.

01, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that management will participate in the following investor conferences:A webcast of the firesi…